The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-[2-hydroxy-2-(2- thienyl)ethyl]4-piperidinyl]N-phenyl-propanamide including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.
Document
Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I
The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 21826
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I,” thefederalregister.org (May 10, 2018), https://thefederalregister.org/documents/2018-10008/schedules-of-controlled-substances-placement-of-beta-hydroxythiofentanyl-into-schedule-i.